Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics in myocardial diseases.

Alicja Bukowska1, Uwe Lendeckel, Thilo Kähne

  • 1Division of Cardiology, Institute of Experimental Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Pathology, Research and Practice
|July 9, 2004
PubMed
Summary

Proteome analysis, including mass spectrometry, offers new insights into cellular mechanisms of cardiac dysfunction by examining protein expression in diseased hearts. This review summarizes current knowledge on proteomic applications in myocardial diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease.

Journal of the American College of Cardiology·2026
Same author

Hospital exemption use of virus-specific T-lymphocytes in children: early experience within the Allovista clinical trial framework.

Frontiers in immunology·2026
Same author

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Admission without consent to a psychiatric ward and length of hospital stay: The role of selected sociodemographic and clinical factors.

International journal of law and psychiatry·2026
Same author

Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF.

European journal of internal medicine·2026

Area of Science:

  • Cardiovascular Medicine
  • Proteomics
  • Molecular Biology

Background:

  • Proteome analysis is increasingly used in cardiovascular medicine to study differential protein expression.
  • Early investigations of myocardial proteomics utilized two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), which has limitations in detecting low-abundance proteins.

Purpose of the Study:

  • To review the current knowledge and applications of proteome analysis in myocardial diseases.
  • To highlight the advancements in proteomics that enable the examination of global protein expression alterations in cardiac dysfunction.

Main Methods:

  • Review of existing literature on proteomic techniques applied to cardiovascular research.
  • Focus on the evolution from 2D-PAGE to more sensitive mass spectrometry-based proteomics.

Related Experiment Videos

  • Analysis of how proteomic data provides insights into cellular mechanisms of cardiac dysfunction.

    • Main Results:

    • Advancements in mass spectrometry have significantly increased sensitivity and detection limits in proteomic analysis.
    • Proteomics allows for a comprehensive examination of protein expression in diseased hearts.
    • This approach is crucial for understanding the cellular basis of cardiac dysfunction.

    Conclusions:

    • Proteomics is a powerful tool for investigating myocardial diseases.
    • Continued advancements in proteomic technology will further enhance our understanding of cardiac pathophysiology.
    • Proteomic insights are vital for developing new diagnostic and therapeutic strategies in cardiovascular medicine.